Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Liabilities (2016 - 2019)

Historic Total Liabilities for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $62.2 billion.

  • Sanofi's Total Liabilities rose 122.0% to $62.2 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $62.2 billion, marking a year-over-year increase of 122.0%. This contributed to the annual value of $59.1 billion for FY2024, which is 418.94% up from last year.
  • Per Sanofi's latest filing, its Total Liabilities stood at $62.2 billion for Q2 2025, which was up 122.0% from $59.1 billion recorded in Q4 2024.
  • In the past 5 years, Sanofi's Total Liabilities ranged from a high of $62.2 billion in Q2 2025 and a low of $53.0 billion during Q4 2022
  • Over the past 5 years, Sanofi's median Total Liabilities value was $59.0 billion (recorded in 2021), while the average stood at $58.0 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 18043.48% in 2021, then plummeted by 1016.32% in 2022.
  • Over the past 5 years, Sanofi's Total Liabilities (Quarter) stood at $59.0 billion in 2021, then decreased by 10.16% to $53.0 billion in 2022, then increased by 6.45% to $56.4 billion in 2023, then increased by 4.75% to $59.1 billion in 2024, then grew by 5.28% to $62.2 billion in 2025.
  • Its last three reported values are $62.2 billion in Q2 2025, $59.1 billion for Q4 2024, and $61.5 billion during Q2 2024.